MedPath
TGA Approval

Hospira irinotecan hydrochloride trihydrate Trihydrate for injection 500 mg/25 mL vial (140608)

140608

Hospira irinotecan hydrochloride trihydrate Trihydrate for injection 500 mg/25 mL vial

Hospira Australia Pty Ltd

June 20, 2007

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

irinotecan hydrochloride trihydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Hospira irinotecan hydrochloride trihydrate Trihydrate for injection 500 mg/25 mL vial (140608) - TGA 批准文号 | MedPath